BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 34536497)

  • 1. In-vitro and in-vivo investigation of amygdalin, metformin, and combination of both against doxorubicin on hepatocellular carcinoma.
    Mamdouh AM; Khodeer DM; Tantawy MA; Moustafa YM
    Life Sci; 2021 Nov; 285():119961. PubMed ID: 34536497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Doxorubicin and curcumin co-delivery by lipid nanoparticles for enhanced treatment of diethylnitrosamine-induced hepatocellular carcinoma in mice.
    Zhao X; Chen Q; Li Y; Tang H; Liu W; Yang X
    Eur J Pharm Biopharm; 2015 Jun; 93():27-36. PubMed ID: 25770771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination chemotherapy of doxorubicin and paclitaxel for hepatocellular carcinoma in vitro and in vivo.
    Jin C; Li H; He Y; He M; Bai L; Cao Y; Song W; Dou K
    J Cancer Res Clin Oncol; 2010 Feb; 136(2):267-74. PubMed ID: 19693537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resveratrol interferes with N-nitrosodiethylamine-induced hepatocellular carcinoma at early and advanced stages in male Wistar rats.
    Rajasekaran D; Elavarasan J; Sivalingam M; Ganapathy E; Kumar A; Kalpana K; Sakthisekaran D
    Mol Med Rep; 2011; 4(6):1211-7. PubMed ID: 21850372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticancer Effect of Amygdalin (Vitamin B-17) on Hepatocellular Carcinoma Cell Line (HepG2) in the Presence and Absence of Zinc.
    El-Desouky MA; Fahmi AA; Abdelkader IY; Nasraldin KM
    Anticancer Agents Med Chem; 2020; 20(4):486-494. PubMed ID: 31958042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic anti-tumor efficacy of doxorubicin and flavopiridol in an in vivo hepatocellular carcinoma model.
    Kwak MS; Yu SJ; Yoon JH; Lee SH; Lee SM; Lee JH; Kim YJ; Lee HS; Kim CY
    J Cancer Res Clin Oncol; 2015 Nov; 141(11):2037-45. PubMed ID: 25989942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrolide antibiotics differentially influence human HepG2 cytotoxicity and modulate intrinsic/extrinsic apoptotic pathways in rat hepatocellular carcinoma model.
    Abdel-Hamid NI; El-Azab MF; Moustafa YM
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Apr; 390(4):379-395. PubMed ID: 28070612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The antitumor activity of a lactosaminated albumin conjugate of doxorubicin in a chemically induced hepatocellular carcinoma rat model compared to sorafenib.
    Elsadek B; Mansour A; Saleem T; Warnecke A; Kratz F
    Dig Liver Dis; 2017 Feb; 49(2):213-222. PubMed ID: 27825923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel 1,2,4-triazole derivatives as antitumor agents against hepatocellular carcinoma.
    Radwan RR; Zaher NH; El-Gazzar MG
    Chem Biol Interact; 2017 Aug; 274():68-79. PubMed ID: 28693887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of Rumex vesicarius as anticancer remedy against hepatocellular carcinoma: a proposal-based on experimental animal studies.
    Shahat AA; Alsaid MS; Kotob SE; Ahmed HH
    Asian Pac J Cancer Prev; 2015; 16(10):4303-10. PubMed ID: 26028090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of co-treatment with doxorubicin and verapamil loaded into chitosan nanoparticles on diethylnitrosamine-induced hepatocellular carcinoma in mice.
    Abo Mansour HE; El-Batsh MM; Badawy NS; Mehanna ET; Mesbah NM; Abo-Elmatty DM
    Hum Exp Toxicol; 2020 Nov; 39(11):1528-1544. PubMed ID: 32519553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Significance of VEGF and HIF-1 α in Hepatocellular Carcinoma Patients Receiving Sorafenib Versus Metformin Sorafenib Combination.
    El Shorbagy S; abuTaleb F; Labib HA; Ebian H; Harb OA; Mohammed MS; Rashied HA; Elbana KA; Haggag R
    J Gastrointest Cancer; 2021 Mar; 52(1):269-279. PubMed ID: 32212089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polo-like kinase 1 as a promising diagnostic biomarker and potential therapeutic target for hepatocellular carcinoma.
    Yousef EH; El-Mesery ME; Habeeb MR; Eissa LA
    Tumour Biol; 2020 Apr; 42(4):1010428320914475. PubMed ID: 32252611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Janus nanocarrier-based co-delivery of doxorubicin and berberine weakens chemotherapy-exacerbated hepatocellular carcinoma recurrence.
    Zhang F; Jia Y; Zheng X; Shao D; Zhao Y; Wang Z; Dawulieti J; Liu W; Sun M; Sun W; Pan Y; Cui L; Wang Y; He K; Zhang M; Li J; Dong WF; Chen L
    Acta Biomater; 2019 Dec; 100():352-364. PubMed ID: 31563690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti cancerous efficacy of Ayurvedic milk extract of Semecarpus anacardium nuts on hepatocellular carcinoma in Wistar rats.
    Joseph JP; Raval SK; Sadariya KA; Jhala M; Kumar P
    Afr J Tradit Complement Altern Med; 2013; 10(5):299-304. PubMed ID: 24311839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vicenin-2 Treatment Attenuated the Diethylnitrosamine-Induced Liver Carcinoma and Oxidative Stress through Increased Apoptotic Protein Expression in Experimental Rats.
    Zhang C; Chen Y; Zhang M; Xu C; Gong G; Veeraraghavan VP; Bolla SR; Li Y
    J Environ Pathol Toxicol Oncol; 2020; 39(2):113-123. PubMed ID: 32749121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PLGA nanoparticles containing α-fetoprotein siRNA induce apoptosis and enhance the cytotoxic effects of doxorubicin in human liver cancer cell line.
    Pho-Iam T; Punnakitikashem P; Somboonyosdech C; Sripinitchai S; Masaratana P; Sirivatanauksorn V; Sirivatanauksorn Y; Wongwan C; Nguyen KT; Srisawat C
    Biochem Biophys Res Commun; 2021 May; 553():191-197. PubMed ID: 33774221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic antitumoral activity and induction of apoptosis by novel pan Bcl-2 proteins inhibitor apogossypolone with adriamycin in human hepatocellular carcinoma.
    Mi JX; Wang GF; Wang HB; Sun XQ; Ni XY; Zhang XW; Tang JM; Yang DJ
    Acta Pharmacol Sin; 2008 Dec; 29(12):1467-77. PubMed ID: 19026166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Asarone and metformin delays experimentally induced hepatocellular carcinoma in diabetic milieu.
    Das BK; Choukimath SM; Gadad PC
    Life Sci; 2019 Aug; 230():10-18. PubMed ID: 31121175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical and pathophysiological improvements in rats with thioacetamide induced-hepatocellular carcinoma using aspirin plus vitamin C.
    El Sadda RR; Elshahawy ZR; Saad EA
    BMC Cancer; 2023 Feb; 23(1):175. PubMed ID: 36809998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.